Navigation Links
BioNeutral's Ygiene(TM) Achieves World's Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test
Date:8/12/2009

NEWARK, N.J., Aug. 12 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology-based Life Science company announced today that ATS Labs using the EPA required AOAC Sporicidal Test with Ygiene(TM) Hospital Grade formula delivered a 100% Total Kill of over one million live Clostridium Sporogenes spores in a four (4) minute time frame - performance which is up to 75 times faster than competitive products such as Steris(R) Spor-Klenz RTU.

"The company is in discussions with a global leader in the health care sector to arrange distribution following our regulatory approval," said Stephen J. Browand, CEO BioNeutral Group Inc. "Our health care market alone is very broad and includes every hospital, nursing home, home health care patient, every immune suppressed patient, emergency room, ambulance, first responder, and doctor, dental, and veterinary office."

"Whether it is the present Swine Flu (H1N1) pandemic or the most difficult to kill dangerous organisms, Bioneutral's technology has given rise to the only family of sporicidal formulations for the hospital/health care sector, industry (including schools) and the home. Performance is unsurpassed, it has a Green environmental profile, is non corrosive, non staining to most fabrics (eg sheets and pillow cases) and can come into contact with skin while remaining sporicidal," said Dr Andy Kielbania PhD, BioNeutral's Chief Scientific Officer.

This EPA required AOAC Sporicidal Test utilizing spore impregnated knotted suture loops is an extremely difficult test to pass especially when starting with over one million Clostridium Sporogenes spores. The rapid elimination of these health threatening microorganisms at health care facilities will reduce the incidents of Hospital Acquired Infections (ACI) and the as
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Independent Laboratory Testing Shows BioNeutrals Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores
2. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
3. Kaiser Permanente Achieves Climate Action Leader Status
4. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
5. LMS integrated obstetrics solution achieves general availability
6. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
7. Pharsight Achieves $7.3 Million in Quarterly Revenue
8. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
9. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
10. Joint Commission International Achieves Accreditation from ISQua
11. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... care and accessible primary care, is enhancing its existing presence in Tennessee with ... Knoxville. The location is the company’s second in Knoxville, sixteenth in Tennessee, and ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... develop skills and assess their competencies in managing challenging conversations, announced today that ... the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... In preparation ... Etymotic Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 Reasons ... amplifiers as a way of coping with a variety of home healthcare challenges, specifically ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... (ACLM), the nation’s medical professional association for physicians and allied health professionals ... the Lifestyle Medicine Foundation, announced today the establishment of the Lifestyle Medicine ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Workgroup for ... of health IT to create efficiencies in healthcare information exchange, announces the agenda ... place at the Hyatt Regency Reston in Reston, Va. from October 26-29, WEDI-Con ...
Breaking Medicine News(10 mins):Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3
... comes to estimating calorie counts, Americans aren,t really on ... Journal of Consumer Research , this may be ... food. "The sequence in which items are considered ... Alexander Chernev (Northwestern University). "The focus on sequential estimation ...
... By Kathleen Doheny HealthDay Reporter ... new studies may help breast cancer patients and ... reconstruction after mastectomy. One study finds that ... after having had a mastectomy with immediate reconstruction ...
... ultimate goal to discover a drug that one day treats ... on pinpointing the mechanisms in the brain that respond to ... in the UH College of Pharmacy, received a three-year, $450,000 ... In the end, his team hopes their research will help ...
... of prostate tumors, promotes the growth of a different type ... online on September 20 in the Journal of Experimental ... and colleagues find that TAL1, a protein abundantly expressed in ... (T-ALL), drives expression of NKX3.1. Eliminating NKX3.1 halted the ...
... might not benefit from some of the tuberculosis vaccines currently ... are designed to activate a specific molecule that is an ... people. But a recent Ohio State University study suggests that ... the face of TB infection. The animal research suggests ...
... of Utah determined that the 2009 pandemic influenza A ... children than the seasonal flu. The most common ... of the study, the most extensive evaluation of neurological ... the September issue of Annals of Neurology , ...
Cached Medicine News:Health News:Low-calorie cheesecake? Why we have trouble estimating calories 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:Drug to treat alcoholism goal of UH professor's research 2Health News:Elderly might not benefit from TB vaccines in development 2Health News:Elderly might not benefit from TB vaccines in development 3Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2
(Date:8/31/2015)... Aug. 31, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), ... of innovative therapeutics for the treatment of diseases of ... that its BNC101 IND submission has passed review by ... to initiate a Phase 1 clinical trial in patients ... pancreatic cancer prior to 31 December 2015. ...
(Date:8/31/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ... "Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ ... Competitors and Opportunities: 2015 - 2020 Analysis and ... Pain is defined as an unpleasant sensory ... tissue damage. At some point, everyone experiences pain. ...
(Date:8/30/2015)... y LONDRES, August 30, 2015 ... una visión holística de l cuidado ... el trayecto   Royal ... el debut europeo de IntelliSpace Cardiovascular , un ... ofrece sofisticadas herramientas para acceder, analizar y compartir imágenes ...
Breaking Medicine Technology:Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... preclinical,data was presented by Nektar Therapeutics (Nasdaq: ... oncolytic candidate, NKTR-102 (PEG-irinotecan), which demonstrated,enhanced anti-tumor ... colorectal,cancer when co-administered with bevacizumab. Presented at ... Meeting 2008 in San Diego,California, the data ...
... Inc.,(Nasdaq: NUVO ) today announced preclinical data ... activity of NU206 (R-spondin1) in,chemotherapy or radiation-induced oral ... session yesterday at the 2008 American Association,for Cancer ... The study, conducted in mouse models of ...
Cached Medicine Technology:Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 2Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 3Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 4Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 5Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models 2Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: